NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Diag-Nose.io

Diag-Nose.io

Private
MelbourneHealthcare & Life Scienceshttps://www.diag-nose.io/

Last Round

Grant

Aug 26, 2025

Total Funding Raised

$4.54M

Company Overview

Diag-Nose.io is a biotechnology company that provides an AI-powered precision medicine platform, RhinoMAP™, which uses proteomics and computational biology to analyze nasal samples for the diagnosis and treatment of chronic respiratory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

precision medicinebiomarker analysisnasal liquid biopsytechbiorespiratory diagnosticsproteomicsmedical aidrug discoverynasal fluid samplingclinical decision supportai diagnosticsdigital healthbiotechdiagnostic hardwarepersonalized medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diag-Nose.io Comparables

Compare Diag-Nose.io with similar companies based on industry and business-model similarity.

Diag-Nose.io comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Noselab GmbH
64%
Owlstone Medical
63%
Illumina, Inc.
60%

Diag-Nose.io Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 26, 2025
SeedJan 29, 2025
GrantAug 19, 2024

Key People

Founding team and executive leadership

Brian Wang

Chief Scientific Officer, Co-Founder

Founding Team

David Yen

Co-Founder And Chief Medical Officer

Founding Team

Eldin Rostom

Co-Founder & CEO

Founding Team

Diag-Nose.io Investors

Notable investors and investment history

Diag-Nose.io investors
InvestorRounds
LaunchVicGrant
Monash UniversityGrant
The ActuatorPre Seed
ArtesianPre Seed
Radar VenturesSeed
Specialty Physician AssociatesSeed
Breakthrough VictoriaSeed

Diag-Nose.io Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Diag-Nose.io Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Diag-Nose.io's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne
Employee Range20
Year Founded2020
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.